To determine the maximum tolerated dose (MTD) of a short-course accelerated radiotherapy and its feasibility for symptomatic palliation of advanced head and neck cancer or head and neck metastases from any primary site.
Phase I-II Study of Short-course Accelerated Radiotherapy (SHARON) for Palliation in Head and Neck Cancer
Caravatta, Luciana
;Genovesi, Domenico
;Cellini, Francesco;
2018-01-01
Abstract
To determine the maximum tolerated dose (MTD) of a short-course accelerated radiotherapy and its feasibility for symptomatic palliation of advanced head and neck cancer or head and neck metastases from any primary site.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Phase I-II Study SHARON.pdf
Solo gestori archivio
Tipologia:
PDF editoriale
Dimensione
114.5 kB
Formato
Adobe PDF
|
114.5 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
